Skip to content

Clinical trials

Phase 1 Glioblastoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1 Country / region: China Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20165
20172
20182
20192
20202
20212
20227
20232
20242
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15
Recruiting11
Completed7
Not yet recruiting3
Active, not recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital5
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Beijing Biotech2
Beijing Sanbo Brain Hospital2
Guangdong 999 Brain Hospital2
Huashan Hospital2
Shanghai Simnova Biotechnology Co.,Ltd.2
Beijing Neurosurgical Institute1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Chinese PLA General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma39
Glioma10
Carcinoma, Hepatocellular3
Medulloblastoma3
Adenoviridae Infections2
Colonic Neoplasms2
Lung Neoplasms2
Neoplasms2
Ovarian Neoplasms2
Small Cell Lung Carcinoma2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.